Loading clinical trials...
Loading clinical trials...
Feasibility Trial of a Hybrid Approach for Treatment of Patients With Persistent or Longstanding Persistent Atrial Fibrillation With Radiofrequency Ablation
Conditions
Interventions
Hybrid: AtriCure Bipolar System & EP ablation procedure
Locations
5
United States
Stanford University Medical Center
Stanford, California, United States
Vanderbilt Heart Institute
Nashville, Tennessee, United States
Baylor Health
Plano, Texas, United States
UVA
Charlottesville, Virginia, United States
Sentara Norfolk
Norfolk, Virginia, United States
Start Date
December 1, 2010
Primary Completion Date
December 1, 2012
Completion Date
November 1, 2013
Last Updated
April 1, 2021
NCT03546374
NCT07301190
NCT05411614
NCT06765356
NCT06106594
NCT06747091
Lead Sponsor
AtriCure, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions